These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24819719)

  • 1. Chemical approaches to targeting drug resistance in cancer stem cells.
    Sotiropoulou PA; Christodoulou MS; Silvani A; Herold-Mende C; Passarella D
    Drug Discov Today; 2014 Oct; 19(10):1547-62. PubMed ID: 24819719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Disease: cancer stem cells--targeting the evil twin.
    Trumpp A; Wiestler OD
    Nat Clin Pract Oncol; 2008 Jun; 5(6):337-47. PubMed ID: 18431377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells--important players in tumor therapy resistance.
    Colak S; Medema JP
    FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of cancer stem cells in the treatment of cancer.
    Pan CX; Zhu W; Cheng L
    Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.
    Yeh CT; Wu AT; Chang PM; Chen KY; Yang CN; Yang SC; Ho CC; Chen CC; Kuo YL; Lee PY; Liu YW; Yen CC; Hsiao M; Lu PJ; Lai JM; Wang LS; Wu CH; Chiou JF; Yang PC; Huang CY
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1180-8. PubMed ID: 23024022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
    Mashima T
    Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways.
    Skvortsov S; Debbage P; Lukas P; Skvortsova I
    Semin Cancer Biol; 2015 Apr; 31():36-42. PubMed ID: 24954010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches for targeting cancer stem cells drug resistance.
    Rosa R; D'Amato V; De Placido S; Bianco R
    Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
    Winquist RJ; Boucher DM; Wood M; Furey BF
    Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of compounds that selectively target highly chemotherapy refractory neuroblastoma cancer stem cells.
    Díaz-Carballo D; Acikelli AH; Bardenheuer W; Gustmann S; Malak S; Stoll R; Kedziorski T; Nazif MA; Jastrow H; Wennemuth G; Dammann P; Feigel M; Strumberg D
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):787-801. PubMed ID: 24902844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARTS-based anticancer therapy: taking aim at cancer stem cells.
    Elhasid R; Larisch S
    Future Oncol; 2011 Oct; 7(10):1185-94. PubMed ID: 21992730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.
    Kim JK; Jeon HY; Kim H
    Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
    Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
    Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. At the crossroads of cancer stem cells and targeted therapy resistance.
    Wang A; Qu L; Wang L
    Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Existing drugs and their application in drug discovery targeting cancer stem cells.
    Lv J; Shim JS
    Arch Pharm Res; 2015 Sep; 38(9):1617-26. PubMed ID: 26152874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.